First Sponsor (ADN) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
29 Oct, 2026Executive summary
PRC property sentiment remained weak and presales subdued; most development projects are advanced, with handovers underway or expected within 15 months. Late-September policy easing prompted cautious optimism for a market recovery.
European property holding income grew in 3Q2024 and 9M2024; a €39.9m share of NSI profit was recognized in 3Q following a change in accounting treatment.
Financial highlights
European property holding operating income was €14.748m in 3Q2024, up 6.0% YoY, and €40.042m for 9M2024, up 15.2%.
European hotel revenue rose 6.3% YoY to €35.15m in 3Q2024 and 6.9% to €97.61m in 9M2024; EBITDA increased 5.8% to €8.07m and 20.6% to €19.35m, respectively.
The NSI accounting change generated a €39.9m share of profit, equivalent to approximately S$57.2m, included in 3Q2024 profit.
Outlook and guidance
Puccini Hotel Milan renovation is expected to complete in 3Q2025; Dreeftoren office completion is delayed one quarter to 3Q2025, while the residential timeline remains under review.
Prins Hendrikkade completion is targeted for 3Q2025, subject to building permit approval; Meerparc's permit application is expected in late 2025, with construction estimated to start in 2026.
Property holding pipeline includes Puccini Milan and Prins Hendrikkade in FY2025, Dreeftoren office and residential in FY2025–FY2026, Sydney Pitt Street Central in FY2027 and Meerparc in FY2028.
PRC property loans will be disbursed cautiously; the loan book is expected to decline further in 4Q2024 following repayments on a Shanghai loan.
Latest events from First Sponsor
- FY2023 profit fell 90.5% as European property income and equity proceeds supported resilience.ADN
H2 2023 - European income and hotel earnings improved as PRC property demand stayed weak.ADN
Q1 2024 TU - Revenue rose 27.2% and profit 12.4%, despite weak PRC pre-sales and higher financing costs.ADN
H1 2024 - NSI earnings lifted FY2024 profit despite PRC weakness and impairment charges.ADN
H2 2024 - Weak PRC presales contrast with stable European income and progress on loan recovery.ADN
Q1 2025 - Attributable profit rose 59.2% despite lower revenue and subdued PRC pre-sales.ADN
H1 2025 - Loan recovery and refinancing bolster flexibility as PRC sales stay weak and European income edges higher.ADN
Q3 2025 TU - Derivative losses drove FY2025 reported loss despite adjusted profit and stronger European hotels.ADN
H2 2025 - H1 attributable loss reached S$92.8m as derivatives and Humen impairment offset European NOI growth.ADN
H1 2026